{
  "ticker": "OCC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972606",
  "id": "02972606",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250725",
  "time": "0904",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250725/pdf/06m45j40gjqp3s.pdf",
  "summary": "**Board Changes Announcement:**  \n- **Kim Beazley AC** steps down as Non-Executive Director (health reasons), remains advisor for US/Defence matters.  \n- **Michael McNulty** appointed as Non-Executive Director and Audit Committee Chair (effective 1 Sept 2025); granted **2M options** (exercise price: $1.53, vesting in 2 years).  \n- **Dr Ravi Thadhani** elevated to Lead Independent Director, leading a new US commercialization committee for **Remplir\u2122**.  \n\n*No material financial or trading-impacting information identified.*",
  "usage": {
    "prompt_tokens": 3659,
    "completion_tokens": 125,
    "total_tokens": 3784,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T23:14:32.925597"
}